https://www.selleckchem.com/products/CUDC-101.html
d FGFR2 fusions.Introduction Biliary tract cancers (BTCs) include four uncommon primary biliary malignancies characterized by poor prognosis intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, gallbladder cancer, and ampulla of Vater cancer. To date, the available therapeutic options are limited; nevertheless, with the advent of targeted therapy and immunotherapy, the treatment scenario is constantly changing, opening toward future possibilities for the personalized treatment of BTC. Among these treatments, nivolumab is c
Like
Comment
Share
